Page last updated: 2024-11-02

phloretin and Breast Cancer

phloretin has been researched along with Breast Cancer in 6 studies

Research Excerpts

ExcerptRelevanceReference
"The inhibitory effect and mechanism of the apple dihydrochalcone, phloretin, on breast cancer cell growth were evaluated in in vitro conditions simulating complete nutrition and glucose-restriction, respectively."8.02The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy. ( Chen, F; Chen, M; Cheng, KW; Gowd, V; Wang, M, 2021)
"Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer."5.48The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter. ( Chen, LC; Chen, ZF; Ho, CT; Ho, YS; Lin, TN; Whang-Peng, J; Wu, KH, 2018)
"The inhibitory effect and mechanism of the apple dihydrochalcone, phloretin, on breast cancer cell growth were evaluated in in vitro conditions simulating complete nutrition and glucose-restriction, respectively."4.02The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy. ( Chen, F; Chen, M; Cheng, KW; Gowd, V; Wang, M, 2021)
"Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer."1.48The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter. ( Chen, LC; Chen, ZF; Ho, CT; Ho, YS; Lin, TN; Whang-Peng, J; Wu, KH, 2018)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Peng, F1
Meng, CW1
Zhou, QM1
Chen, JP1
Xiong, L1
Roy, S1
Mondru, AK1
Chakraborty, T1
Das, A1
Dasgupta, S1
Chen, M1
Gowd, V1
Wang, M1
Chen, F1
Cheng, KW1
Wu, KH1
Ho, CT1
Chen, ZF1
Chen, LC1
Whang-Peng, J1
Lin, TN1
Ho, YS1
DIETRICH, LS1
Schöndorf, T1
Kurbacher, CM1
Becker, M1
Warm, M1
Kolhagen, H1
Göhring, UJ1

Other Studies

6 other studies available for phloretin and Breast Cancer

ArticleYear
Cytotoxic Evaluation against Breast Cancer Cells of Isoliquiritigenin Analogues from Spatholobus suberectus and Their Synthetic Derivatives.
    Journal of natural products, 2016, Jan-22, Volume: 79, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Proliferation; Chalcones; Drug Screening A

2016
Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.
    Toxicology and applied pharmacology, 2022, 01-01, Volume: 434

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female

2022
The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy.
    Food & function, 2021, Jan-07, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survi

2021
The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter.
    Journal of food and drug analysis, 2018, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tum

2018
AUGMENTATION OF 6-AMINONICOTINAMIDE ANTAGONISM OF TUMOR GROWTH BY COMPOUNDS WITH ESTROGENIC ACTIVITY.
    Cancer research, 1964, Volume: 24

    Topics: 6-Aminonicotinamide; Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Cortisone; Di

1964
Heterogeneity of proteinkinase C activity and PKC-zeta expression in clinical breast carcinomas.
    Clinical and experimental medicine, 2001, Volume: 1, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms

2001